Ayabudge LLC - Sep 15, 2022 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role: 10%+ Owner
Signature: /s/ Ayabudge LLC by Dale A. Sander as Attorney-in-Fact
Stock symbol: HUMA
Transactions as of: Sep 15, 2022
Transactions value $: -$6,090,000
Form type: 4
Date filed: 9/19/2022, 04:33 PM
Previous filing: Aug 27, 2021
Next filing: Dec 15, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HUMA	Common Stock	Sale	-$6.09M	-1.52M	-7.44%	$4.00	18.9M	Sep 15, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale was made by the Reporting Person in a block trade. The purchaser is an existing investor of the Issuer, who had previously participated in the Issuer's PIPE financing transaction, and was interested in increasing its ownership of the Humacyte, Inc. The transaction enabled Mr. Brady Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the purchaser to acquire a large block of shares at a time that Humacyte, Inc. was not conducting a financing and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer.

Content

The sale was made by the Reporting Person in a block trade. The purchaser is an existing investor of the Issuer, who had previously participated in the Issuer's PIPE financing transaction, and was interested in increasing its ownership of the Humacyte, Inc. The transaction enabled Mr. Brady Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the purchaser to acquire a large block of shares at a time that Humacyte, Inc. was not conducting a financing and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer.